Seeking Alpha

AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board....

AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board. Profit fell 29% Y/Y, primarily due to costs related to a recall of some its NeverTouch procedure kits. Gross margin was also down, reflecting the impact of ongoing programs to reduce material costs and increase its manufacturing efficiency.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|